- Home
- JTAI vs BDRX Comparison
JTAI vs BDRX Comparison
Compare JTAI & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- BDRX
- Stock Information
- Founded
- JTAI 2018
- BDRX 2000
- Country
- JTAI United States
- BDRX United Kingdom
- Employees
- JTAI N/A
- BDRX N/A
- Industry
- JTAI Blank Checks
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- BDRX Health Care
- Exchange
- JTAI Nasdaq
- BDRX Nasdaq
- Market Cap
- JTAI 9.9M
- BDRX 5.8M
- IPO Year
- JTAI N/A
- BDRX N/A
- Fundamental
- Price
- JTAI $3.70
- BDRX $0.87
- Analyst Decision
- JTAI
- BDRX
- Analyst Count
- JTAI 0
- BDRX 0
- Target Price
- JTAI N/A
- BDRX N/A
- AVG Volume (30 Days)
- JTAI 208.7K
- BDRX 3.1M
- Earning Date
- JTAI 08-13-2025
- BDRX 04-11-2025
- Dividend Yield
- JTAI N/A
- BDRX N/A
- EPS Growth
- JTAI N/A
- BDRX N/A
- EPS
- JTAI N/A
- BDRX N/A
- Revenue
- JTAI $13,648,668.00
- BDRX N/A
- Revenue This Year
- JTAI $13.37
- BDRX N/A
- Revenue Next Year
- JTAI $201.13
- BDRX N/A
- P/E Ratio
- JTAI N/A
- BDRX N/A
- Revenue Growth
- JTAI N/A
- BDRX N/A
- 52 Week Low
- JTAI $2.30
- BDRX $0.78
- 52 Week High
- JTAI $97.40
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- JTAI 49.53
- BDRX 38.67
- Support Level
- JTAI $3.33
- BDRX $0.85
- Resistance Level
- JTAI $3.75
- BDRX $0.92
- Average True Range (ATR)
- JTAI 0.21
- BDRX 0.06
- MACD
- JTAI 0.03
- BDRX 0.01
- Stochastic Oscillator
- JTAI 59.68
- BDRX 32.73
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.